To get a better sense of what drug concentrations are needed to inhibit mutant RyR2 channels, we assessed the effects of different doses of EL20 on CaSpF in evoked iPSC‐CMs derived from the CPVT proband. The gene discussed is RYR2; the disease is catecholaminergic polymorphic ventricular tachycardia.